rs551207815
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022051.3(EGLN1):c.311C>T(p.Ser104Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,312,802 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S104S) has been classified as Likely benign.
Frequency
Consequence
NM_022051.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EGLN1 | NM_022051.3 | c.311C>T | p.Ser104Phe | missense_variant | 1/5 | ENST00000366641.4 | NP_071334.1 | |
EGLN1 | NM_001377260.1 | c.311C>T | p.Ser104Phe | missense_variant | 1/4 | NP_001364189.1 | ||
EGLN1 | NM_001377261.1 | c.311C>T | p.Ser104Phe | missense_variant | 1/4 | NP_001364190.1 | ||
EGLN1 | XM_024447734.2 | c.311C>T | p.Ser104Phe | missense_variant | 1/3 | XP_024303502.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EGLN1 | ENST00000366641.4 | c.311C>T | p.Ser104Phe | missense_variant | 1/5 | 1 | NM_022051.3 | ENSP00000355601.3 | ||
ENSG00000287856 | ENST00000662216.1 | c.30+40860C>T | intron_variant | ENSP00000499467.1 | ||||||
ENSG00000287856 | ENST00000653908.1 | c.30+40860C>T | intron_variant | ENSP00000499669.1 | ||||||
ENSG00000287856 | ENST00000653198.1 | n.433+40894C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 156AN: 151740Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000235 AC: 1AN: 4256Hom.: 0 AF XY: 0.000397 AC XY: 1AN XY: 2518
GnomAD4 exome AF: 0.000152 AC: 176AN: 1160954Hom.: 1 Cov.: 31 AF XY: 0.000129 AC XY: 72AN XY: 560308
GnomAD4 genome AF: 0.00103 AC: 156AN: 151848Hom.: 0 Cov.: 32 AF XY: 0.00117 AC XY: 87AN XY: 74230
ClinVar
Submissions by phenotype
Erythrocytosis, familial, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 104 of the EGLN1 protein (p.Ser104Phe). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with EGLN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 407205). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 09, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Observed in individuals with a personal or family history including hereditary erythrocytosis and pheochromocytoma (Oliveira et al., 2018; Ben Aim et al., 2019); This variant is associated with the following publications: (PMID: 29790589, 30877234) - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at